Moxidectin (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Moxidectin" in English language version.

refsWebsite

Global rank English rank

16nih.gov

4^th place

10doi.org

2^nd place

1canada.ca

1,712^th place

1,063^rd place

1semanticscholar.org

11^th place

8^th place

1archive.org

6^th place

archive.org

Patel A, Forsythe P (2008). Small animal dermatology. Edinburgh: Elsevier/Saunders. p. 26. ISBN 9780702028700.

canada.ca

health-products.canada.ca

"Cydectin Product information". Health Canada. 25 April 2012. Retrieved 29 May 2022.

doi.org

Old JM, Skelton C, Stannard HJ (2021). "The use of Cydectin® by wildlife carers to treat sarcoptic mange in free-ranging bare-nosed wombats (Vombatus ursinus)". Parasitology Research. 120 (3): 1077–1090. doi:10.1007/s00436-020-07012-8. PMID 33438043.
Awadzi K, Opoku NO, Attah SK, Lazdins-Helds J, Kuesel AC (June 2014). "A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection". PLOS Neglected Tropical Diseases. 8 (6): e2953. doi:10.1371/journal.pntd.0002953. PMC 4072596. PMID 24968000.
Maheu-Giroux M, Joseph SA (August 2018). "Moxidectin for deworming: from trials to implementation". The Lancet. Infectious Diseases. 18 (8): 817–819. doi:10.1016/S1473-3099(18)30270-6. PMID 29858152. S2CID 46921091.
Turner HC, Walker M, Attah SK, Opoku NO, Awadzi K, Kuesel AC, et al. (March 2015). "The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data". Parasites & Vectors. 8: 167. doi:10.1186/s13071-015-0779-4. PMC 4381491. PMID 25889256.
Wolstenholme AJ, Fairweather I, Prichard R, von Samson-Himmelstjerna G, Sangster NC (October 2004). "Drug resistance in veterinary helminths". Trends in Parasitology. 20 (10): 469–476. doi:10.1016/j.pt.2004.07.010. PMID 15363440.
Blackhall WJ, Prichard RK, Beech RN (March 2008). "P-glycoprotein selection in strains of Haemonchus contortus resistant to benzimidazoles". Veterinary Parasitology. 152 (1–2): 101–107. doi:10.1016/j.vetpar.2007.12.001. PMID 18241994.
Mounsey KE, Bernigaud C, Chosidow O, McCarthy JS (March 2016). "Prospects for Moxidectin as a New Oral Treatment for Human Scabies". PLOS Neglected Tropical Diseases. 10 (3): e0004389. doi:10.1371/journal.pntd.0004389. PMC 4795782. PMID 26985995.
Schraven AL, Stannard HJ, Old JM (2021). "A systematic review of moxidectin as a treatment for parasitic infections in mammalian species". Parasitology Research. 120 (4): 1167–1181. doi:10.1007/s00436-021-07092-0. PMID 33615411.
Baynes RE, Payne M, Martin-Jimenez T, Abdullah AR, Anderson KL, Webb AI, et al. (September 2000). "Extralabel use of ivermectin and moxidectin in food animals". Journal of the American Veterinary Medical Association. 217 (5): 668–671. doi:10.2460/javma.2000.217.668. PMID 10976297.{{cite journal}}: CS1 maint: overridden setting (link)
Lumaret JP, Errouissi F, Floate K, Römbke J, Wardhaugh K (May 2012). "A review on the toxicity and non-target effects of macrocyclic lactones in terrestrial and aquatic environments". Current Pharmaceutical Biotechnology. 13 (6): 1004–1060. doi:10.2174/138920112800399257. PMC 3409360. PMID 22039795.

nih.gov

pubmed.ncbi.nlm.nih.gov

Old JM, Skelton C, Stannard HJ (2021). "The use of Cydectin® by wildlife carers to treat sarcoptic mange in free-ranging bare-nosed wombats (Vombatus ursinus)". Parasitology Research. 120 (3): 1077–1090. doi:10.1007/s00436-020-07012-8. PMID 33438043.
Awadzi K, Opoku NO, Attah SK, Lazdins-Helds J, Kuesel AC (June 2014). "A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection". PLOS Neglected Tropical Diseases. 8 (6): e2953. doi:10.1371/journal.pntd.0002953. PMC 4072596. PMID 24968000.
Maheu-Giroux M, Joseph SA (August 2018). "Moxidectin for deworming: from trials to implementation". The Lancet. Infectious Diseases. 18 (8): 817–819. doi:10.1016/S1473-3099(18)30270-6. PMID 29858152. S2CID 46921091.
Turner HC, Walker M, Attah SK, Opoku NO, Awadzi K, Kuesel AC, et al. (March 2015). "The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data". Parasites & Vectors. 8: 167. doi:10.1186/s13071-015-0779-4. PMC 4381491. PMID 25889256.
Wolstenholme AJ, Fairweather I, Prichard R, von Samson-Himmelstjerna G, Sangster NC (October 2004). "Drug resistance in veterinary helminths". Trends in Parasitology. 20 (10): 469–476. doi:10.1016/j.pt.2004.07.010. PMID 15363440.
Blackhall WJ, Prichard RK, Beech RN (March 2008). "P-glycoprotein selection in strains of Haemonchus contortus resistant to benzimidazoles". Veterinary Parasitology. 152 (1–2): 101–107. doi:10.1016/j.vetpar.2007.12.001. PMID 18241994.
Mounsey KE, Bernigaud C, Chosidow O, McCarthy JS (March 2016). "Prospects for Moxidectin as a New Oral Treatment for Human Scabies". PLOS Neglected Tropical Diseases. 10 (3): e0004389. doi:10.1371/journal.pntd.0004389. PMC 4795782. PMID 26985995.
Schraven AL, Stannard HJ, Old JM (2021). "A systematic review of moxidectin as a treatment for parasitic infections in mammalian species". Parasitology Research. 120 (4): 1167–1181. doi:10.1007/s00436-021-07092-0. PMID 33615411.
Baynes RE, Payne M, Martin-Jimenez T, Abdullah AR, Anderson KL, Webb AI, et al. (September 2000). "Extralabel use of ivermectin and moxidectin in food animals". Journal of the American Veterinary Medical Association. 217 (5): 668–671. doi:10.2460/javma.2000.217.668. PMID 10976297.{{cite journal}}: CS1 maint: overridden setting (link)
Lumaret JP, Errouissi F, Floate K, Römbke J, Wardhaugh K (May 2012). "A review on the toxicity and non-target effects of macrocyclic lactones in terrestrial and aquatic environments". Current Pharmaceutical Biotechnology. 13 (6): 1004–1060. doi:10.2174/138920112800399257. PMC 3409360. PMID 22039795.

ncbi.nlm.nih.gov

"milbemycin". MeSH - NCBI. Retrieved 21 July 2017.
Awadzi K, Opoku NO, Attah SK, Lazdins-Helds J, Kuesel AC (June 2014). "A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection". PLOS Neglected Tropical Diseases. 8 (6): e2953. doi:10.1371/journal.pntd.0002953. PMC 4072596. PMID 24968000.
Turner HC, Walker M, Attah SK, Opoku NO, Awadzi K, Kuesel AC, et al. (March 2015). "The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data". Parasites & Vectors. 8: 167. doi:10.1186/s13071-015-0779-4. PMC 4381491. PMID 25889256.
Mounsey KE, Bernigaud C, Chosidow O, McCarthy JS (March 2016). "Prospects for Moxidectin as a New Oral Treatment for Human Scabies". PLOS Neglected Tropical Diseases. 10 (3): e0004389. doi:10.1371/journal.pntd.0004389. PMC 4795782. PMID 26985995.
Lumaret JP, Errouissi F, Floate K, Römbke J, Wardhaugh K (May 2012). "A review on the toxicity and non-target effects of macrocyclic lactones in terrestrial and aquatic environments". Current Pharmaceutical Biotechnology. 13 (6): 1004–1060. doi:10.2174/138920112800399257. PMC 3409360. PMID 22039795.

dailymed.nlm.nih.gov

"MOXIDECTIN tablet". Dailymed. U.S. National Library of Medicine.

semanticscholar.org

api.semanticscholar.org

Maheu-Giroux M, Joseph SA (August 2018). "Moxidectin for deworming: from trials to implementation". The Lancet. Infectious Diseases. 18 (8): 817–819. doi:10.1016/S1473-3099(18)30270-6. PMID 29858152. S2CID 46921091.